We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

64 hedge funds and large institutions have $96.1M invested in Soleno Therapeutics in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

310% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 10

300% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 4

98% more capital invested

Capital invested by funds: $48.5M → $96.1M (+$47.6M)

94% more funds holding

Funds holding: 33 → 64 (+31)

56% more call options, than puts

Call options by funds: $4.74M | Put options by funds: $3.04M

0.75% more ownership

Funds ownership: 3.1% → 3.85% (+0.75%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
64
Holders Change
+31
Holders Change %
+93.94%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
41
Increased
16
Reduced
4
Closed
10
Calls
$4.74M
Puts
$3.04M
Net Calls
+$1.7M
Net Calls Change
+$1.7M

Top Buyers

Rank Fund Capital Flow
1
A
Abingworth
United Kingdom
+$9.63M
2
NCM
Nantahala Capital Management
Connecticut
+$9.1M
3
CCM
Consonance Capital Management
New York
+$8.78M
4
SCM
Suvretta Capital Management
New York
+$7.3M
5
GPCM
Granite Point Capital Management
Massachusetts
+$6.36M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$4.81M
2
6CM
683 Capital Management
New York
-$952K
3
OIM
Oracle Investment Management
Connecticut
-$579K
4
Millennium Management
Millennium Management
New York
-$272K
5
TMC
Trellus Management Company
Florida
-$231K
Name Holding Trade Value Shares
Change 		Change in
Stake
Baird Financial Group
26
Baird Financial Group
Wisconsin
$243K +$316K +7,287 New
Nuveen
27
Nuveen
North Carolina
$223K +$289K +6,672 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$173K +$224K +5,179 New
MCM
29
Moore Capital Management
New York
$167K +$217K +5,000 New
Charles Schwab
30
Charles Schwab
California
$160K +$208K +4,804 New
VF
31
Virtu Financial
New York
$153K +$199K +4,594 New
OC
32
Oppenheimer & Co
New York
$136K +$2.9K +67 +2%
Wells Fargo
33
Wells Fargo
California
$125K +$162K +3,743 +41,589%
Jane Street
34
Jane Street
New York
$125K +$163K +3,771 New
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$117K +$152K +3,513 New
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$112K – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$112K +$146K +3,362 New
BBVA
38
Banco Bilbao Vizcaya Argentaria
Spain
$111K – – –
Two Sigma Investments
39
Two Sigma Investments
New York
$107K +$140K +3,225 New
BFM
40
Boothbay Fund Management
New York
$94K +$123K +2,832 New
Millennium Management
41
Millennium Management
New York
$91K -$272K -6,280 -70%
AllianceBernstein
42
AllianceBernstein
Tennessee
$77K +$100K +2,307 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$72K +$93.9K +2,166 New
JP Morgan Chase
44
JP Morgan Chase
New York
$61K +$79.8K +1,841 New
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$46K +$59.5K +1,374 New
AIG
46
American International Group
New York
$45K +$59.1K +1,364 New
UBS Group
47
UBS Group
Switzerland
$41K +$38.6K +891 +253%
SG Americas Securities
48
SG Americas Securities
New York
$40K +$52K +1,200 New
Barclays
49
Barclays
United Kingdom
$40K +$52.8K +1,219 New
Morgan Stanley
50
Morgan Stanley
New York
$35K +$43.9K +1,012 +3,748%
1
2
3

SLNO Hedge Fund Activity: Q2 2020 in Review

64 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q2 2020, worth a combined $96.1M — up 98% from $48.5M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new SLNO positions and 10 closed out — a net gain of 31 holders — while 16 added to existing stakes and 4 trimmed.

The largest buyer was Abingworth, adding an estimated $9.63M. The largest seller was Vivo Capital, exiting entirely with an estimated $4.81M sold.

  • 64 institutional investors held Soleno Therapeutics (SLNO) as of Q2 2020, up from 33 in Q1 2020.
  • Funds reported $96.1M of Soleno Therapeutics stock for Q2 2020, up 98% quarter-over-quarter.
  • 41 funds opened new Soleno Therapeutics positions in Q2 2020 and 10 closed out, a net change of +31 holders.
  • The largest Soleno Therapeutics buyer in Q2 2020 was Abingworth, an estimated $9.63M added.
  • The largest Soleno Therapeutics seller in Q2 2020 was Vivo Capital, an estimated $4.81M sold.

Based on aggregated 13F filings for Q2 2020.